China bans 15 products over heart disease concern
November 1st, 2010 - 12:23 pm ICT by IANSBeijing, Nov 1 (IANS) China has banned 15 weight-loss products containing a drug that could lead to increased risk of heart disease.
The State Food and Drug Administration (SFDA) has banned the production, sale and use of all anti-obesity medications containing sibutramine, China Daily reported Monday.
The drug watchdog made the decision after a latest research on sibutramine revealed that the risks of using these products outweighed the potential benefits to obese patients.
Sibutramine is the chief ingredient in the anti-obesity medication that alters a patient’s appetite and metabolism. It was introduced as an anti-obesity medication in the US in 1997 and received approval from the SFDA in China in 2000.
Producers have been asked to recall and destroy products containing the drug.
The ban on sibutramine in China follows the US FDA’s decision in October to remove the drug from the market after tests established that it raised blood pressure and posed a risk to patients’ cardiovascular systems.
The EU, Australia and Canada also pulled products containing the drug earlier this year.
Ma Qian, a 24-year-old woman from Beijing, said she took one such product to lose weight, but stopped taking it after experiencing rapid heart beat and vomiting.
Lu Changlin, a cardiologist at the Beijing Tongren Hospital, said sibutramine would not impair a patient’s health over a short period, but the drug could harm cardiac muscles and valves if it is taken for over 12 months. “And the damage is irreversible,” he said.
- FDA Advisory Panel Recommends Contrave's Approval - Dec 09, 2010
- 76 officials punished over medicine scandal in China - Aug 04, 2012
- Anti-obesity drugs dull brain pleasure centres to 'food porn' - Oct 27, 2010
- Weight loss pill 'could be deadly' - Jan 17, 2010
- Weight-loss drug increases blood pressure: Review - Jul 10, 2009
- FDA Advisory Committee Rejects Vivus Inc. Weight Loss Pill - Jul 19, 2010
- Europe bans anti-obesity drug Reductil - Jan 26, 2010
- FDA rejects weight loss pill - Jul 19, 2010
- Weight loss pill linked to heart attacks, stroke risk - Jan 04, 2010
- Keller Rohrback to continue investigation of Abbot Laboratories' weight loss drug Merida - Oct 10, 2010
- Obesity drug withdrawn over heart attack, stroke risk - Jan 22, 2010
- No breast implant ruptures reported in China - Jan 07, 2012
- China to check inferior food products - Feb 22, 2012
- Potential mechanisms that contribute to 'I am full' feeling identified - Mar 04, 2011
- Gurgaon runs to spread awareness about obesity - Feb 19, 2012
Tags: beijing tongren hospital, cardiac muscles, cardiologist, cardiovascular systems, chief ingredient, china daily, food and drug, food and drug administration, heart disease, metabolism, nov 1, obesity medication, obesity medications, old woman, rapid heart beat, risk of heart disease, sfda, sibutramine, state food, watchdog